REBECCA SEWELL: Open Payments
NPI 1992291603 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $149 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Amgen Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $25 |
| Corium, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Wegovy, AIRSUPRA, KRYSTEXXA, Ozempic, JARDIANCE, UBRELVY, Azstarys, REXULTI.
Industry payments across AL — which companies pay providers there.
